Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has announced the appointment of Ashok K. Saluja, Ph.D., as the inaugural Director of the new Sylvester Pancreatic Cancer Research Institute at the Miller School of Medicine (SPCRI) and Associate Director for Research Innovation, Senior Associate Dean for Research, as well as professor and vice chair of surgery.
Sakir Humayun Gultekin, M.D., has joined Sylvester Comprehensive Cancer Center and the Department of Pathology & Laboratory Medicine at the University of Miami Miller School of Medicine and UHealth. Gultekin will serve as Director of Clinical and Molecular Neuropathology for the University of Miami Brain Tumor Initiative, where he will support its comprehensive brain tumor program via clinical and basic science research.
During the Team Showcase Competition at the 24th Annual Florida Sterling Conference on June 3, the Sylvester Comprehensive Cancer Center Laboratory team presented on the topic of “Safety Matters: Decreasing Blood Transfusion Turnaround Time at Sylvester Comprehensive Cancer Center” and won an award in the “Best Use of Tools” category. The team was also named the “Overall Runner Up” among all six participating organizations.
Neurological surgeons at Sylvester Comprehensive Cancer Center traded in their scrubs for softball gear to raise money for pediatric brain tumor research, raising more than $100,000 at the J. Lawrence Pool Neurosurgery Softball Tournament held in Central Park in New York City on June 11.
The Pap Corps recently announced a $4 million gift for cancer research at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. The gift includes funds raised through a partnership with the Dolphins Cancer Challenge and is the third-largest gift in the history of the Pap Corps.
A new study by prostate cancer researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has characterized the active surveillance criteria in Hispanic men, marking the first such study in this population.
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has conducted two new studies that may help guide prognosis and treatment of uveal melanomas. Building on key discoveries made in recent years, the research team, led by J. William Harbour, M.D., an eye cancer expert at Sylvester, factored tumor size and mutations into a patient’s prognosis.